KENNETH BATE Insider Trading $EPZM Epizyme, Inc.
Get free email notifications about insider trading for KENNETH BATE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of KENNETH BATE. KENNETH BATE is EVP; Chief Financial Officer in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and ExecVP; Head of Commercial Ops in MILLENNIUM PHARMACEUTICALS INC ($MLNM) and Director in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in MADRIGAL PHARMACEUTICALS, INC. ($SNTA) and Director in AVEO PHARMACEUTICALS INC ($AVEO) and Director in Vanda Pharmaceuticals Inc. ($VNDA) and Director in CATABASIS PHARMACEUTICALS INC ($CATB) and Director in GENOCEA BIOSCIENCES, INC. ($GNCA) and Director in Epizyme, Inc. ($EPZM).
KENNETH BATE in Epizyme, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of KENNETH BATE: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 02 2020
$EPZM Market Capitalization: $707.73M
$EPZM Previous Close: $12.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of KENNETH BATE in Epizyme, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AVEO, BMRN, CATB, EPZM, GNCA, SNTA, MLNM, VNDA
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 02 2020 | EPZM | Epizyme, Inc. | BATE KENNETH | Director | Option Exercise | A | 17.55 | 14,013 | 245,928 | 14,013 | |
| Jun 07 2019 | EPZM | Epizyme, Inc. | BATE KENNETH | Director | Option Exercise | A | 13.74 | 17,633 | 242,277 | 17,633 | |
| May 31 2018 | EPZM | Epizyme, Inc. | BATE KENNETH | Director | Option Exercise | A | 17.00 | 12,500 | 212,500 | 12,500 | |
| Jun 26 2017 | EPZM | Epizyme, Inc. | BATE KENNETH | Director | Option Exercise | A | 13.65 | 12,500 | 170,625 | 12,500 | |
| May 23 2016 | EPZM | Epizyme, Inc. | BATE KENNETH | Director | Option Exercise | A | 9.33 | 12,500 | 116,625 | 12,500 | |
| Jul 10 2015 | EPZM | Epizyme, Inc. | BATE KENNETH | Director | Option Exercise | A | 22.78 | 7,333 | 167,046 | 7,333 |
Page: 1